Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/2250
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBello, Marcelo Adeodato-
dc.contributor.authorMenezes, Raquel Ferreira de-
dc.contributor.authorSilva, Brunna de Sousa-
dc.contributor.authorSilva, Rafael de Carvalho da-
dc.contributor.authorCavalcanti, Rousiane Silva-
dc.contributor.authorMoraes, Thayane de Fátima da Costa-
dc.contributor.authorTonellotto, Fabiana-
dc.contributor.authorAguiar, Suzana Sales de-
dc.contributor.authorMartucci, Renata Brum-
dc.contributor.authorBergmann, Anke-
dc.contributor.authorThuler, Luiz Claudio Santos-
dc.date.accessioned2021-04-28T18:48:22Z-
dc.date.available2021-04-28T18:48:22Z-
dc.date.issued2016-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/2250-
dc.description.abstractObjective: To analyze the survival of elderly patients with breast cancer according to the type of treatment used. Methods: A cohort study of women aged 80 or over with breast cancer registered with the Brazilian National Cancer Institute (Instituto Nacional do Câncer - INCA) between 2008 and 2009 was conducted. Prognosis was analyzed according to the cancer treatment performed: surgery, radiotherapy, or hormone therapy. Analysis of the overall 5-year survival rate was performed using the Kaplan - Meier method, and comparisons of curves were undertaken using the log-rank test. For multiple regression analysis, Cox regression was used, adjusting for age and clinical stage, considering values of p < 0.05 as significant. Data were all analyzed using the statistical package SPSS version 20. Results: 70 women with a mean age of 84.0 ± 3.7 years at diagnosis participated in the study. The median follow-up time was 37.1 months (range 0.5–75.5), and 31 deaths (44.3%) occurred during this time. The median survival time was 51.2 months (95% CI, 44.9–57.4), higher in those who underwent surgery (p = 0.012) and those who had hormone therapy (p=0.001). Treatment with surgery reduced the risk of death by 61.7% (HR 0.3; 95% CI, 0.1–0.6; p = 0.001) when adjusted for clinical stage and age at diagnosis. However, there was no significant benefit from radiotherapy (HR 1.2; 95% CI, 0.5–2.5; p = 0.694). Conclusion: Treatment with surgery and hormone therapy increased the survival of our Brazilian patients with breast cancer aged 80 or over.pt_BR
dc.language.isoen_USpt_BR
dc.publisherAsian Pacific Journal of Cancer Preventionpt_BR
dc.relation.ispartofseries17;-
dc.subjectBreast Neoplasmspt_BR
dc.subjectAgedpt_BR
dc.subjectTherapeuticspt_BR
dc.subjectNeoplasias da Mama-
dc.subjectIdoso-
dc.subjectNeoplasias de la Mama-
dc.subjectAnciano-
dc.subjectTerapêutica-
dc.subjectTerapéutica-
dc.titleImpact of treatment type on overall survival in elderly brazilian women with breast cancerpt_BR
dc.TypeArticlept_BR
Appears in Collections:Hospital do Câncer III (HCIII)

Files in This Item:
File Description SizeFormat 
Marcelo Bello não consta no Lattes 5.pdfImpact of Treatment Type on Overall Survival in Elderly Brazilian Women with Breast Cancer346.23 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.